Hubungan Ansietas Dengan Penyakit Parkinson Pada Pasien Rawat Jalan Di Poliklinik Neurologi RSUP Dr. M. Djamil Padang
Anxiety is one of the most common non-motor symptom in Parkinson's disesase which greatly affects oatients’ quality of life, however it’s often neglected in clinical practice. The purpose of this study was to determine the rate and association between anxiety and Parkinson's disease using Hamilton Anxiety Rating Scale (HAR). This was a cross sectional study conducted at Neurology Polyclinic of Dr. M. Djamil Padang General Hospital. Sample was taken by consecutive sampling method. There were 60 patients diagnosed with Parkinson's disease who met inclusion criteria. Male (55%) patients were more common than female (45%) and most patients aged more than 50 years (63%). Based on the HARS assessment obtained 23 patients with anxiety and 37 patients without anxiety. There were significant associations among duration of illness, staging, and marital status with anxiety in Parkinson’s disease.
2. Massano J, Bhatia KP. Clinical approach to Parkinson’s disease: Features, diagnosis, and principles of management. Cold Spring Harbor Perspectives in Medicine [Internet]. 2012 [cited 2021 Feb 13];2(6). Available from: /pmc/articles/PMC3367535/
3. Borgonovo J, Allende-Castro C, Laliena A, Guerrero N, Silva H, Concha ML. Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson’s disease [Internet]. Vol. 35, Parkinsonism and Related Disorders. Elsevier Ltd; 2017 [cited 2021 Feb 13]. p. 17–24. Available from: http://www.prd-journal.com/article/S1353802016304540/fulltext
4. Dissanayaka NNNW, White E, O’Sullivan JD, Marsh R, Pachana NA, Byrne GJ. The clinical spectrum of anxiety in Parkinson’s disease [Internet]. Vol. 29, Movement Disorders. John Wiley and Sons Inc.; 2014 [cited 2021 Feb 13]. p. 967–75. Available from: https://pubmed.ncbi.nlm.nih.gov/25043800/
5. Reynolds GO, Hanna KK, Neargarder S, Cronin-Golomb A. The relation of anxiety and cognition in Parkinson’s disease. Neuropsychology. 2017 Sep 1;31(6):596–604.
6. Broen MPG, Narayen NE, Kuijf ML, Dissanayaka NNW, Leentjens AFG. Prevalence of anxiety in Parkinson’s disease: A systematic review and meta-analysis [Internet]. Vol. 31, Movement Disorders. John Wiley and Sons Inc.; 2016 [cited 2021 Feb 13]. p. 1125–33. Available from: https://pubmed.ncbi.nlm.nih.gov/27125963/
7. Menon B, Nayar R, Kumar S, Cherkil S, Venkatachalam A, Surendran K, et al. Parkinson’s Disease, Depression, and Quality-of-Life. Indian Journal of Psychological Medicine [Internet]. 2015 Apr 1 [cited 2021 Feb 13];37(2):144–8. Available from: www.ijpm.info
8. Moisan F, Kab S, Mohamed F, Canonico M, Le Guern M, Quintin C, et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry [Internet]. 2016 Sep 1 [cited 2021 Feb 13];87(9):952–7. Available from: https://pubmed.ncbi.nlm.nih.gov/26701996/
9. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: A systematic review and meta-analysis [Internet]. Vol. 29, Movement Disorders. John Wiley and Sons Inc.; 2014 [cited 2021 Feb 13]. p. 1583–90. Available from: https://pubmed.ncbi.nlm.nih.gov/24976103/
10. Tysnes OB, Storstein A. Epidemiology of Parkinson’s disease [Internet]. Vol. 124, Journal of Neural Transmission. Springer-Verlag Wien; 2017 [cited 2021 Feb 13]. p. 901–5. Available from: https://pubmed.ncbi.nlm.nih.gov/28150045/
11. Pagano G, Ferrara N, Brooks DJ, Pavese N. Age at onset and Parkinson disease phenotype. Neurology [Internet]. 2016 Apr 12 [cited 2021 Feb 13];86(15):1400–7. Available from: /pmc/articles/PMC4831034/
12. Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson’s disease [Internet]. Vol. 17, The Lancet Neurology. Lancet Publishing Group; 2018 [cited 2021 Feb 13]. p. 559–68. Available from: https://pubmed.ncbi.nlm.nih.gov/29699914/
13. Khedr EM, Abdelrahman AA, Elserogy Y, Zaki AF, Gamea A. Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life. Egyptian Journal of Neurology, Psychiatry and Neurosurgery [Internet]. 2020 Dec 1 [cited 2021 Feb 13];56(1):116. Available from: https://ejnpn.springeropen.com/articles/10.1186/s41983-020-00253-5
14. Andreadou E, Anagnostouli M, Vasdekis V, Kararizou E, Rentzos M, Kontaxis T, et al. The impact of comorbidity and other clinical and sociodemographic factors on health-related quality of life in Greek patients with Parkinson’s disease. Aging and Mental Health. 2011 Sep;15(7):913–21.
15. Hanna KK, Cronin-Golomb A. Impact of anxiety on quality of life in parkinson’s disease. Parkinson’s Disease [Internet]. 2012 [cited 2021 Feb 13];2012. Available from: /pmc/articles/PMC3236448/
16. Chuquilín-Arista F, Álvarez-Avellón T, Menéndez-González M. Prevalence of Depression and Anxiety in Parkinson Disease and Impact on Quality of Life: A Community-Based Study in Spain. Journal of Geriatric Psychiatry and Neurology [Internet]. 2020 Jul 1 [cited 2021 Feb 13];33(4):207–13. Available from: https://pubmed.ncbi.nlm.nih.gov/31597514
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All articles published Open Access are free for everyone to read and download. Under the CC-BY-SA license, authors retain ownership of the copyright for their article, but authors grant others permission to use the content of publications in WoH in whole or in part provided that the original work is properly cited.
Users (redistributors) of WoH are required to cite the original source, including the author's names, WoH as the initial source of publication, year of publication, and volume number